Cargando…

Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease

Healthy expansion of adipose tissue is critical for the maintenance of metabolic health, providing an optimized reservoir for energy storage in the form of triacylglycerol-rich lipoproteins. Dysfunctional adipocytes that are unable to efficiently store lipid can result in lipodystrophy and contribut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunasekar, Susheel K., Heebink, John, Carpenter, Danielle H., Kumar, Ashutosh, Xie, Litao, Zhang, Haixia, Schilling, Joel D., Sah, Rajan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077479/ https://www.ncbi.nlm.nih.gov/pubmed/36749637 http://dx.doi.org/10.1172/jci.insight.154940

Ejemplares similares

SWELL signalling in adipocytes: can fat 'feel' fat?
por: Gunasekar, Susheel K., et al.
Publicado: (2019)

SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism
por: Kumar, Ashutosh, et al.
Publicado: (2020)

Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes
por: Gunasekar, Susheel K., et al.
Publicado: (2022)

SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia
por: Kang, Chen, et al.
Publicado: (2018)

SWELL1 is a regulator of adipocyte size, insulin signaling and glucose homeostasis
por: Zhang, Yanhui, et al.
Publicado: (2017)

The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function
por: Alghanem, Ahmad F, et al.
Publicado: (2021)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
por: Sakane, Sadatsugu, et al.
Publicado: (2021)

Conditional deletion of LRRC8A in the brain reduces stroke damage independently of swelling-activated glutamate release
por: Balkaya, Mustafa, et al.
Publicado: (2023)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice
por: Tsai, Hsiao-Pei, et al.
Publicado: (2021)

LepRb(+) cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice
por: Kim, Min-Hyun, et al.
Publicado: (2023)

Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2023)

Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice
por: Wang, Min, et al.
Publicado: (2023)

MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice
por: Yu, Yuanjie, et al.
Publicado: (2022)

Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index
por: Chen, Xueyu, et al.
Publicado: (2022)

Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
por: Chang, Geng-Ruei, et al.
Publicado: (2021)

Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes
por: Barata, Llilda, et al.
Publicado: (2019)

The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients
por: Arab, Arman, et al.
Publicado: (2017)

Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
por: Maseroli, E., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
por: Chiu, Chien-Chao, et al.
Publicado: (2017)

Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs
por: Yamada, Sohsuke, et al.
Publicado: (2017)

Early but Not Late Exercise Training in Mice Exacerbates Hepatic Inflammation in Developing Nonalcoholic Fatty Liver Disease
por: Kovynev, Artemiy, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers
por: Cree-Green, Melanie, et al.
Publicado: (2019)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study
por: Pang, Yuanjie, et al.
Publicado: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children
por: Prokopowicz, Zofia, et al.
Publicado: (2018)

Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype
por: Yun, Chun-Ho, et al.
Publicado: (2022)

Kcne2 deletion causes early-onset nonalcoholic fatty liver disease via iron deficiency anemia
por: Lee, Soo Min, et al.
Publicado: (2016)

Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility
por: Kamfar, Sharareh, et al.
Publicado: (2016)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study
por: Kure, Takeshi, et al.
Publicado: (2019)

The Importance of Visceral Adipose Tissue Detected by Imaging Methods to Assess Nonalcoholic Fatty Liver Disease Properly
por: Ozcelik, Fatih, et al.
Publicado: (2021)

Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue
por: Petrescu, Maria, et al.
Publicado: (2022)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
por: Cartland, Siân P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m26cc3t4a3puli37hrp65h0f7v